Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 73

1.

Serial measurements of KL-6 for monitoring activity and recurrence of interstitial pneumonia with anti-aminoacyl-tRNA synthetase antibody: A retrospective cohort study.

Yamaguchi K, Iwamoto H, Sakamoto S, Horimasu Y, Masuda T, Miyamoto S, Nakashima T, Ohshimo S, Fujitaka K, Hamada H, Kohno N, Hattori N.

Medicine (Baltimore). 2018 Dec;97(49):e13542. doi: 10.1097/MD.0000000000013542.

PMID:
30544464
2.

A Simplified Gas Chromatographic Fatty-Acid Analysis by the Direct Saponification/Methylation Procedure and Its Application on Wild Tuna Larvae.

Matsumoto Y, Ando Y, Hiraoka Y, Tawa A, Ohshimo S.

Lipids. 2018 Sep;53(9):919-929. doi: 10.1002/lipd.12098. Epub 2018 Nov 9.

PMID:
30411800
3.

2018 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations Summary.

Soar J, Donnino MW, Maconochie I, Aickin R, Atkins DL, Andersen LW, Berg KM, Bingham R, Böttiger BW, Callaway CW, Couper K, Couto TB, de Caen AR, Deakin CD, Drennan IR, Guerguerian AM, Lavonas EJ, Meaney PA, Nadkarni VM, Neumar RW, Ng KC, Nicholson TC, Nuthall GA, Ohshimo S, O'Neil BJ, Ong GY, Paiva EF, Parr MJ, Reis AG, Reynolds JC, Ristagno G, Sandroni C, Schexnayder SM, Scholefield BR, Shimizu N, Tijssen JA, Van de Voorde P, Wang TL, Welsford M, Hazinski MF, Nolan JP, Morley PT; ILCOR Collaborators.

Resuscitation. 2018 Dec;133:194-206. doi: 10.1016/j.resuscitation.2018.10.017. Epub 2018 Nov 5.

PMID:
30409433
4.

Changes in serum KL-6 levels are associated with the development of chronic lung allograft dysfunction in lung transplant recipients.

Bessa V, Bonella F, Ohshimo S, Weinreich G, Kleibrink B, Costabel U, Aigner C, Kamler M, Taube C, Sommerwerck U.

Transpl Immunol. 2018 Nov 1. pii: S0966-3274(18)30082-0. doi: 10.1016/j.trim.2018.10.006. [Epub ahead of print]

PMID:
30391371
5.

Focusing on Risk Factors of Cardiac Arrest During Intubation in ICU Again.

Tanabe Y, Ohshimo S, Shime N.

Crit Care Med. 2018 Nov;46(11):e1082. doi: 10.1097/CCM.0000000000003337. No abstract available.

PMID:
30312240
6.

Should We Abandon Airway Pressure Release Ventilation in Pediatric Acute Respiratory Distress Syndrome?

Kyo M, Ohshimo S, Shime N.

Am J Respir Crit Care Med. 2018 Dec 1;198(11):1459-1460. doi: 10.1164/rccm.201807-1274LE. No abstract available.

PMID:
30148970
7.

Comparison of extracorporeal membrane oxygenation outcome for influenza-associated acute respiratory failure in Japan between 2009 and 2016.

Ohshimo S, Shime N, Nakagawa S, Nishida O, Takeda S; Committee of the Japan ECMO project.

J Intensive Care. 2018 Jul 11;6:38. doi: 10.1186/s40560-018-0306-8. eCollection 2018.

8.

Does Dysphagia After Extubation Really Increase Mortality?

Iwasaki Y, Ohshimo S, Shime N.

Crit Care Med. 2018 Jul;46(7):e726-e727. doi: 10.1097/CCM.0000000000003118. No abstract available.

PMID:
29912127
9.

Rapid-onset plasma leakage of extracorporeal oxygenation membranes possibly due to hyperbilirubinemia.

Kida Y, Ohshimo S, Kyo M, Tanabe Y, Suzuki K, Hosokawa K, Shime N.

J Artif Organs. 2018 Dec;21(4):475-478. doi: 10.1007/s10047-018-1051-4. Epub 2018 Jun 2.

PMID:
29860680
10.

Use of proton pump inhibitors is associated with increased mortality due to nosocomial pneumonia in bedridden patients receiving tube feeding.

Hamai K, Iwamoto H, Ohshimo S, Wakabayashi Y, Ihara D, Fujitaka K, Hamada H, Ono K, Hattori N.

Geriatr Gerontol Int. 2018 Aug;18(8):1215-1218. doi: 10.1111/ggi.13450. Epub 2018 May 22.

PMID:
29785745
11.

An emerging frontier in the treatment of acute exacerbation of idiopathic pulmonary fibrosis.

Ohshimo S, Costabel U, Shime N.

Respir Investig. 2018 Mar;56(2):97-99. doi: 10.1016/j.resinv.2017.12.003. Epub 2017 Dec 27. No abstract available.

PMID:
29548662
12.

Target blood pressure for septic and vasodilatory shock: what is optimal?

Ishii J, Ohshimo S, Shime N, Lamontagne F, Guyatt G, Asfar P.

Intensive Care Med. 2018 Apr;44(4):548-549. doi: 10.1007/s00134-018-5127-7. Epub 2018 Mar 12. No abstract available.

PMID:
29532095
13.

Potential confounders affecting the reintubation rate : Discussion on "Reconnection to mechanical ventilation for 1 h after a successful spontaneous breathing trial reduces reintubation in critically ill patients: a multicenter randomized controlled trial".

Kikutani K, Ohshimo S, Shime N, Del Mar Fernandez M, Fernandez R.

Intensive Care Med. 2018 Apr;44(4):542-543. doi: 10.1007/s00134-018-5082-3. Epub 2018 Feb 21. No abstract available.

PMID:
29468330
14.

Accurate Quantification of Pleural Effusion and Cofactors Affecting Weaning Failure.

Iwasaki Y, Ohshimo S, Shime N.

Anesthesiology. 2018 Mar;128(3):678-679. doi: 10.1097/ALN.0000000000002041. No abstract available.

PMID:
29438247
15.

Confounders for interpreting the benefit of a biomarker-based strategy in early discontinuation of empirical antifungal therapy.

Yamaga S, Ohshimo S, Shime N, Nseir S, Sendid B, Rouzé A.

Intensive Care Med. 2018 Mar;44(3):399-400. doi: 10.1007/s00134-018-5068-1. Epub 2018 Feb 2. No abstract available.

PMID:
29396654
16.

Is Oxygenation Really an Intrinsic Predictive Factor of Mortality in Patients Undergoing Extracorporeal Life Support?

Ishii J, Ohshimo S, Shime N.

Crit Care Med. 2018 Feb;46(2):e181-e182. doi: 10.1097/CCM.0000000000002810. No abstract available.

PMID:
29337819
17.

AGER rs2070600 polymorphism elevates neutrophil-lymphocyte ratio and mortality in metastatic lung adenocarcinoma.

Yamaguchi K, Iwamoto H, Sakamoto S, Horimasu Y, Masuda T, Miyamoto S, Nakashima T, Ohshimo S, Fujitaka K, Hamada H, Hattori N.

Oncotarget. 2017 Oct 10;8(55):94382-94392. doi: 10.18632/oncotarget.21764. eCollection 2017 Nov 7.

18.

Potential Confounders of Procalcitonin-Guided Antibiotic Therapy for Sepsis.

Kikutani K, Ohshimo S, Shime N.

Crit Care Med. 2017 Dec;45(12):e1310-e1311. doi: 10.1097/CCM.0000000000002713. No abstract available.

PMID:
29149015
19.

Confounders Affecting the Prognosis in Patients With Acute Decompensated Heart Failure Who Underwent Extracorporeal Membrane Oxygenation.

Kyo M, Ohshimo S, Shime N.

Crit Care Med. 2017 Dec;45(12):e1309. doi: 10.1097/CCM.0000000000002718. No abstract available.

PMID:
29149013
20.

The extent of ground-glass attenuation is a risk factor of chemotherapy-related exacerbation of interstitial lung disease in patients with non-small cell lung cancer.

Masuda T, Hirano C, Horimasu Y, Nakashima T, Miyamoto S, Iwamoto H, Ohshimo S, Fujitaka K, Hamada H, Hattori N.

Cancer Chemother Pharmacol. 2018 Jan;81(1):131-139. doi: 10.1007/s00280-017-3476-5. Epub 2017 Nov 15.

PMID:
29143072
21.

Does enhanced antibiotic de-escalation really have no benefit in the ICU?

Ohki S, Ohshimo S, Shime N.

Crit Care. 2017 Nov 2;21(1):270. doi: 10.1186/s13054-017-1845-4. No abstract available.

22.

Potential factors affecting lung inhomogeneity in acute respiratory distress syndrome.

Tanabe Y, Ohshimo S, Shime N.

Intensive Care Med. 2018 Jan;44(1):125-126. doi: 10.1007/s00134-017-4897-7. Epub 2017 Oct 6. No abstract available.

PMID:
29038889
23.

Impact of biology knowledge on the conservation and management of large pelagic sharks.

Yokoi H, Ijima H, Ohshimo S, Yokawa K.

Sci Rep. 2017 Sep 6;7(1):10619. doi: 10.1038/s41598-017-09427-3.

24.

Combined rupture of left ventricular free wall and pericardium.

Kyo M, Ohshimo S, Ota K, Shime N.

Intensive Care Med. 2017 Dec;43(12):1858-1859. doi: 10.1007/s00134-017-4921-y. Epub 2017 Sep 4. No abstract available.

PMID:
28871307
25.

Gene expression profiling of idiopathic interstitial pneumonias (IIPs): identification of potential diagnostic markers and therapeutic targets.

Horimasu Y, Ishikawa N, Taniwaki M, Yamaguchi K, Hamai K, Iwamoto H, Ohshimo S, Hamada H, Hattori N, Okada M, Arihiro K, Ohtsuki Y, Kohno N.

BMC Med Genet. 2017 Aug 18;18(1):88. doi: 10.1186/s12881-017-0449-9.

26.

Differential diagnosis of granulomatous lung disease: clues and pitfalls: Number 4 in the Series "Pathology for the clinician" Edited by Peter Dorfmüller and Alberto Cavazza.

Ohshimo S, Guzman J, Costabel U, Bonella F.

Eur Respir Rev. 2017 Aug 9;26(145). pii: 170012. doi: 10.1183/16000617.0012-2017. Print 2017 Sep 30. Review.

27.

The clinical practice guideline for the management of ARDS in Japan.

Hashimoto S, Sanui M, Egi M, Ohshimo S, Shiotsuka J, Seo R, Tanaka R, Tanaka Y, Norisue Y, Hayashi Y, Nango E; ARDS clinical practice guideline committee from the Japanese Society of Respiratory Care Medicine and the Japanese Society of Intensive Care Medicine.

J Intensive Care. 2017 Jul 25;5:50. doi: 10.1186/s40560-017-0222-3. eCollection 2017.

28.

Serum YKL-40 is a reliable biomarker for pulmonary alveolar proteinosis.

Bonella F, Long X, He X, Ohshimo S, Griese M, Guzman J, Costabel U.

Respirology. 2017 Oct;22(7):1371-1378. doi: 10.1111/resp.13082. Epub 2017 May 31.

29.

Optimal Cutoff Value for Lung Injury Prediction Score and Potential Confounders for Identifying the Risk of Developing Acute Respiratory Distress Syndrome.

Kida Y, Ohshimo S, Shime N.

Crit Care Med. 2017 Jun;45(6):e624-e625. doi: 10.1097/CCM.0000000000002353. No abstract available.

PMID:
28509751
30.

Next Step to Understanding Subphenotypes of Acute Respiratory Distress Syndrome.

Shimatani T, Ohshimo S, Shime N.

Am J Respir Crit Care Med. 2017 Sep 15;196(6):795-796. doi: 10.1164/rccm.201703-0604LE. No abstract available.

PMID:
28406711
31.

MUC1 in lung adenocarcinoma: cross-sectional genetic and serological study.

Horimasu Y, Ishikawa N, Tanaka S, Hirano C, Iwamoto H, Ohshimo S, Fujitaka K, Hamada H, Hattori N, Kohno N.

BMC Cancer. 2017 Apr 12;17(1):263. doi: 10.1186/s12885-017-3272-y.

32.

Is Higher Cerebral Oxygen Saturation Really Predictive of Favorable Neurologic Outcome After In-Hospital Cardiac Arrest?

Miyoshi H, Ohshimo S, Shime N.

Crit Care Med. 2017 Apr;45(4):e468-e469. doi: 10.1097/CCM.0000000000002228. No abstract available.

PMID:
28291120
33.

AGER gene polymorphisms and soluble receptor for advanced glycation end product in patients with idiopathic pulmonary fibrosis.

Yamaguchi K, Iwamoto H, Horimasu Y, Ohshimo S, Fujitaka K, Hamada H, Mazur W, Kohno N, Hattori N.

Respirology. 2017 Jul;22(5):965-971. doi: 10.1111/resp.12995. Epub 2017 Feb 14.

PMID:
28198072
34.

FAM13A polymorphism as a prognostic factor in patients with idiopathic pulmonary fibrosis.

Hirano C, Ohshimo S, Horimasu Y, Iwamoto H, Fujitaka K, Hamada H, Hattori N, Shime N, Bonella F, Guzman J, Costabel U, Kohno N.

Respir Med. 2017 Feb;123:105-109. doi: 10.1016/j.rmed.2016.12.007. Epub 2016 Dec 22.

PMID:
28137485
35.

Outcome Prediction for Acute Respiratory Distress Syndrome: Are the Current Three Variables Really Optimal?

Tanabe Y, Ohshimo S, Shime N.

Crit Care Med. 2017 Feb;45(2):e237-e238. doi: 10.1097/CCM.0000000000002151. No abstract available.

PMID:
28098646
36.

Potential Confounders of the Accuracy and Reliability of Delirium Assessment Tools.

Ohki S, Ohshimo S, Shime N.

Crit Care Med. 2017 Jan;45(1):e114. No abstract available.

PMID:
27984294
37.

Serum YKL-40 as predictor of outcome in hypersensitivity pneumonitis.

Long X, He X, Ohshimo S, Griese M, Sarria R, Guzman J, Costabel U, Bonella F.

Eur Respir J. 2017 Feb 23;49(2). pii: 1501924. doi: 10.1183/13993003.01924-2015. Print 2017 Feb.

38.

Is transpulmonary pressure-guided PEEP titration really optimal?

Yamaga S, Ohshimo S, Shime N.

Intensive Care Med. 2016 Nov;42(11):1845-1846. Epub 2016 Sep 19. No abstract available.

PMID:
27647329
39.

Exploring Potential Cofactors Affecting Coagulation and Inflammation Activity During Extracorporeal Membrane Oxygenation.

Kida Y, Ohshimo S, Shime N.

Crit Care Med. 2016 Nov;44(11):e1149-e1150. No abstract available.

PMID:
27755091
40.

Potential covariates that affect post-extubation breathing effort in children.

Kida Y, Ohshimo S, Shime N.

Intensive Care Med. 2016 Dec;42(12):2127-2128. doi: 10.1007/s00134-016-4538-6. Epub 2016 Oct 14. No abstract available.

PMID:
27743000
41.

Are probiotics actually useful in decreasing VAP rate?

Suzuki K, Ohshimo S, Shime N.

Intensive Care Med. 2016 Oct;42(10):1643-1644. doi: 10.1007/s00134-016-4419-z. Epub 2016 Sep 12. No abstract available.

PMID:
27620299
42.

Factors affecting biomarkers of endothelial and alveolar epithelial dysfunction.

Kyo M, Ohshimo S, Shime N.

Intensive Care Med. 2016 Dec;42(12):2111-2112. doi: 10.1007/s00134-016-4460-y. Epub 2016 Aug 17. No abstract available.

PMID:
27535563
43.

Pediatric cardiorespiratory failure successfully managed with venoarterial-venous extracorporeal membrane oxygenation: a case report.

Kyo M, Ohshimo S, Kida Y, Shimatani T, Torikoshi Y, Suzuki K, Yamaga S, Hirohashi N, Shime N.

BMC Pulm Med. 2016 Aug 12;16(1):119. doi: 10.1186/s12890-016-0280-7.

44.

Exploring Causative Pathology Is Essential for Validating Harmful Effects of Late Intubation.

Kyo M, Ohshimo S, Shime N.

Crit Care Med. 2016 Aug;44(8):e770-1. doi: 10.1097/CCM.0000000000001787. No abstract available.

PMID:
27428149
45.

Comparative Study of Circulating MMP-7, CCL18, KL-6, SP-A, and SP-D as Disease Markers of Idiopathic Pulmonary Fibrosis.

Hamai K, Iwamoto H, Ishikawa N, Horimasu Y, Masuda T, Miyamoto S, Nakashima T, Ohshimo S, Fujitaka K, Hamada H, Hattori N, Kohno N.

Dis Markers. 2016;2016:4759040. doi: 10.1155/2016/4759040. Epub 2016 May 17.

46.

Long-term pulmonary complications of chemical weapons exposure in former poison gas factory workers.

Nishimura Y, Iwamoto H, Ishikawa N, Hattori N, Horimasu Y, Ohshimo S, Fujitaka K, Kondo K, Hamada H, Awai K, Kohno N.

Inhal Toxicol. 2016 Jul;28(8):343-8. doi: 10.3109/08958378.2016.1173133. Epub 2016 Apr 25.

PMID:
27109836
47.

MUC1 gene polymorphisms are associated with serum KL-6 levels and pulmonary dysfunction in pulmonary alveolar proteinosis.

Bonella F, Long X, Ohshimo S, Horimasu Y, Griese M, Guzman J, Kohno N, Costabel U.

Orphanet J Rare Dis. 2016 Apr 23;11:48. doi: 10.1186/s13023-016-0430-2.

48.

Innovation in Analysis of Respiratory Sounds.

Ohshimo S, Sadamori T, Tanigawa K.

Ann Intern Med. 2016 May 3;164(9):638-9. doi: 10.7326/L15-0350. Epub 2016 Feb 16. No abstract available.

PMID:
26882464
49.

A pilot study: a combined therapy using polymyxin-B hemoperfusion and extracorporeal membrane oxygenation for acute exacerbation of interstitial pneumonia.

Itai J, Ohshimo S, Kida Y, Ota K, Iwasaki Y, Hirohashi N, Bonella F, Guzman J, Costabel U, Kohno N, Tanigawa K.

Sarcoidosis Vasc Diffuse Lung Dis. 2015 Jan 5;31(4):343-9.

PMID:
25591146
50.

MUC5B promoter polymorphism in Japanese patients with idiopathic pulmonary fibrosis.

Horimasu Y, Ohshimo S, Bonella F, Tanaka S, Ishikawa N, Hattori N, Kohno N, Guzman J, Costabel U.

Respirology. 2015 Apr;20(3):439-44. doi: 10.1111/resp.12466. Epub 2015 Jan 8.

Supplemental Content

Loading ...
Support Center